Retroviral retention activates a Syk-dependent HemITAM in Human tetherin

Cell Host and Microbe

Volumn 16, Issue 3, 2014, Pages 291-303

  Galão, Rui Pedro ^a   Pickering, Suzanne ^a   Curnock, Rachel ^b   Neil, Stuart J D ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LECTIN; PROTEIN KINASE SYK; PROTEIN RICH2; RAC PROTEIN; TETHERIN; UNCLASSIFIED DRUG; BST2 PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; LEUKOCYTE ANTIGEN; PROTEIN TYROSINE KINASE; RICH2 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ACTIN FILAMENT; ARTICLE; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; NONHUMAN; PROTEIN PHOSPHORYLATION; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; RETROVIRUS; SIGNAL TRANSDUCTION; VIRION; VIRUS CELL TRANSFORMATION; VIRUS PARTICLE; CHEMISTRY; ENZYMOLOGY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN MOTIF;

AMINO ACID MOTIFS; ANTIGENS, CD; GPI-LINKED PROTEINS; GTPASE-ACTIVATING PROTEINS; HIV INFECTIONS; HIV-1; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NF-KAPPA B; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 84907692616     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2014.08.005     Document Type: Article

References (39)

1. J.F. Arias, L.N. Heyer, B. von Bredow, K.L. Weisgrau, B. Moldt, D.R. Burton, E.G. Rakasz, and D.T. Evans Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity Proc. Natl. Acad. Sci. USA 111 2014 6425 6430
2. B.S. Barrett, D.S. Smith, S.X. Li, K. Guo, K.J. Hasenkrug, and M.L. Santiago A single nucleotide polymorphism in tetherin promotes retrovirus restriction in vivo PLoS Pathog. 8 2012 e1002596
3. W. Cao, L. Bover, M. Cho, X. Wen, S. Hanabuchi, M. Bao, D.B. Rosen, Y.H. Wang, J.L. Shaw, and Q. Du Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction J. Exp. Med. 206 2009 1603 1614
4. D.H. Chu, C.T. Morita, and A. Weiss The Syk family of protein tyrosine kinases in T-cell activation and development Immunol. Rev. 165 1998 167 180
5. L.J. Cocka, and P. Bates Identification of alternatively translated Tetherin isoforms with differing antiviral and signaling activities PLoS Pathog. 8 2012 e1002931
6. G.L. Fuller, J.A. Williams, M.G. Tomlinson, J.A. Eble, S.L. Hanna, S. Pöhlmann, K. Suzuki-Inoue, Y. Ozaki, S.P. Watson, and A.C. Pearce The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade J. Biol. Chem. 282 2007 12397 12409
7. R.P. Galão, A. Le Tortorec, S. Pickering, T. Kueck, and S.J. Neil Innate sensing of HIV-1 assembly by Tetherin induces NFκB-dependent proinflammatory responses Cell Host Microbe 12 2012 633 644
8. N. Götz, D. Sauter, S.M. Usmani, J.V. Fritz, C. Goffinet, A. Heigele, M. Geyer, F. Bibollet-Ruche, G.H. Learn, and O.T. Fackler Reacquisition of Nef-mediated tetherin antagonism in a single in vivo passage of HIV-1 through its original chimpanzee host Cell Host Microbe 12 2012 373 380
9. C. Goujon, T. Schaller, R.P. Galão, S.M. Amie, B. Kim, K. Olivieri, S.J. Neil, and M.H. Malim Evidence for IFNα-induced, SAMHD1-independent inhibitors of early HIV-1 infection Retrovirology 10 2013 23
10. A.G. Hise, J. Tomalka, S. Ganesan, K. Patel, B.A. Hall, G.D. Brown, and K.A. Fitzgerald An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans Cell Host Microbe 5 2009 487 497
11. S. Kupzig, V. Korolchuk, R. Rollason, A. Sugden, A. Wilde, and G. Banting Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology Traffic 4 2003 694 709
12. S. Le Clerc, C. Coulonges, O. Delaneau, D. Van Manen, J.T. Herbeck, S. Limou, P. An, J.J. Martinson, J.L. Spadoni, and A. Therwath Screening low-frequency SNPS from genome-wide association study reveals a new risk allele for progression to AIDS J. Acquir. Immune Defic. Syndr. 56 2011 279 284
13. S.X. Li, B.S. Barrett, K.J. Heilman, R.J. Messer, R.A. Liberatore, P.D. Bieniasz, G. Kassiotis, K.J. Hasenkrug, and M.L. Santiago Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo J. Immunol. 193 2014 306 316
14. R.A. Liberatore, and P.D. Bieniasz Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo Proc. Natl. Acad. Sci. USA 108 2011 18097 18101
15. J. Martin-Serrano, D. Perez-Caballero, and P.D. Bieniasz Context-dependent effects of L domains and ubiquitination on viral budding J. Virol. 78 2004 5554 5563
16. E. Miyagi, A.J. Andrew, S. Kao, and K. Strebel Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion Proc. Natl. Acad. Sci. USA 106 2009 2868 2873
17. S.J. Neil The antiviral activities of tetherin Curr. Top. Microbiol. Immunol. 371 2013 67 104
18. S.J. Neil, S.W. Eastman, N. Jouvenet, and P.D. Bieniasz HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane PLoS Pathog. 2 2006 e39
19. S.J. Neil, T. Zang, and P.D. Bieniasz Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu Nature 451 2008 425 430
20. D. Perez-Caballero, T. Zang, A. Ebrahimi, M.W. McNatt, D.A. Gregory, M.C. Johnson, and P.D. Bieniasz Tetherin inhibits HIV-1 release by directly tethering virions to cells Cell 139 2009 499 511
21. S. Pickering, S. Hué, E.Y. Kim, S. Reddy, S.M. Wolinsky, and S.J. Neil Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals PLoS Pathog. 10 2014 e1003895
22. A.Y. Pollitt, B. Grygielska, B. Leblond, L. Désiré, J.A. Eble, and S.P. Watson Phosphorylation of CLEC-2 is dependent on lipid rafts, actin polymerization, secondary mediators, and Rac Blood 115 2010 2938 2946
23. R. Rollason, V. Korolchuk, C. Hamilton, P. Schu, and G. Banting Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif J. Cell Sci. 120 2007 3850 3858
24. R. Rollason, V. Korolchuk, C. Hamilton, M. Jepson, and G. Banting A CD317/tetherin-RICH2 complex plays a critical role in the organization of the subapical actin cytoskeleton in polarized epithelial cells J. Cell Biol. 184 2009 721 736
25. D. Sancho, O.P. Joffre, A.M. Keller, N.C. Rogers, D. Martínez, P. Hernanz-Falcón, I. Rosewell, and C. Reis e Sousa Identification of a dendritic cell receptor that couples sensing of necrosis to immunity Nature 458 2009 899 903
26. D. Sauter, M. Schindler, A. Specht, W.N. Landford, J. Münch, K.A. Kim, J. Votteler, U. Schubert, F. Bibollet-Ruche, and B.F. Keele Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains Cell Host Microbe 6 2009 409 421
27. D. Sauter, M. Vogl, and F. Kirchhoff Ancient origin of a deletion in human BST2/Tetherin that confers protection against viral zoonoses Hum. Mutat. 32 2011 1243 1245
28. D. Sauter, D. Unterweger, M. Vogl, S.M. Usmani, A. Heigele, S.F. Kluge, E. Hermkes, M. Moll, E. Barker, and M. Peeters Human tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein PLoS Pathog. 8 2012 e1003093
29. D. Sauter, D. Hotter, S. Engelhart, F. Giehler, A. Kieser, C. Kubisch, and F. Kirchhoff A rare missense variant abrogates the signaling activity of tetherin/BST-2 without affecting its effect on virus release Retrovirology 10 2013 85
30. R. Serra-Moreno, B. Jia, M. Breed, X. Alvarez, and D.T. Evans Compensatory changes in the cytoplasmic tail of gp41 confer resistance to tetherin/BST-2 in a pathogenic nef-deleted SIV Cell Host Microbe 9 2011 46 57
31. S. Séverin, A.Y. Pollitt, L. Navarro-Nuñez, C.A. Nash, D. Mourão-Sá, J.A. Eble, Y.A. Senis, and S.P. Watson Syk-dependent phosphorylation of CLEC-2: a novel mechanism of hem-immunoreceptor tyrosine-based activation motif signaling J. Biol. Chem. 286 2011 4107 4116
32. J.R. St-Germain, P. Taylor, J. Tong, L.L. Jin, A. Nikolic, I.I. Stewart, R.M. Ewing, M. Dharsee, Z. Li, S. Trudel, and M.F. Moran Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibition Proc. Natl. Acad. Sci. USA 106 2009 20127 20132
33. D. Strasser, K. Neumann, H. Bergmann, M.J. Marakalala, R. Guler, A. Rojowska, K.P. Hopfner, F. Brombacher, H. Urlaub, and G. Baier Syk kinase-coupled C-type lectin receptors engage protein kinase C-σ to elicit Card9 adaptor-mediated innate immunity Immunity 36 2012 32 42
34. K. Suzuki-Inoue, G.L. Fuller, A. García, J.A. Eble, S. Pöhlmann, O. Inoue, T.K. Gartner, S.C. Hughan, A.C. Pearce, and G.D. Laing A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2 Blood 107 2006 542 549
35. B. Tavano, R.P. Galao, D.R. Graham, S.J. Neil, V.N. Aquino, D. Fuchs, and A. Boasso Ig-like transcript 7, but not bone marrow stromal cell antigen 2 (also known as HM1.24, tetherin, or CD317), modulates plasmacytoid dendritic cell function in primary human blood leukocytes J. Immunol. 190 2013 2622 2630
36. A. Tokarev, M. Suarez, W. Kwan, K. Fitzpatrick, R. Singh, and J. Guatelli Stimulation of NF-κB activity by the HIV restriction factor BST2 J. Virol. 87 2013 2046 2057
37. M. Veillette, A. Désormeaux, H. Medjahed, N.E. Gharsallah, M. Coutu, J. Baalwa, Y. Guan, G. Lewis, G. Ferrari, and B.H. Hahn Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity J. Virol. 88 2014 2633 2644
38. S. Venkatesh, and P.D. Bieniasz Mechanism of HIV-1 virion entrapment by tetherin PLoS Pathog. 9 2013 e1003483
39. J. Weinelt, and S.J. Neil Differential sensitivities of tetherin isoforms to counteraction by primate lentiviruses J. Virol. 88 2014 5845 5858